Modulight Biotherapeutics Inks $12M Seed Funding
Summary
Modulight Biotherapeutics closed a $12.2 million seed round to advance its optogenetic platform for neurological disorders. Jibe Ventures and LocalGlobe led the round, with additional participation from several other investors. The company plans to use the capital to accelerate development of its therapeutic product pipeline and move toward clinical-stage progress. The announcement centers on a life sciences company developing software-enabled therapeutic technology, which makes it relevant to the ISV audience.
Funding
Amount
$12.0M
Total raised
Date
November 13, 2025
Announcement date
Investors
LocalGlobe
Lead investors
Company
https://www.modulight.bio
Funded company
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected